BioCentrum Obtains a Certificate of Good Laboratory Practice (GLP)

23-May-2011 - Poland

BioCentrum, part of the Selvita Group, received a certificate of compliance with the principles of Good Laboratory Practice (GLP). The certificate was awarded after a successfully completed verification by the Bureau for Chemical Substances (institution of governmental administration granting GLP certificates).

GLP Certificate No 3/2011/DPL covers all the activities of the BioCentrum’s Cell Laboratory, including analytical and clinical chemistry testing, as well as in vitro tests in the area of cytotoxicity of chemical substances. This certificate has been issued for an indefinite period of time, however its subject to compulsory re-certification in 2 years from the date of the issue.

GLP certification marks a very important step in the company’s development. It provides evidence that the services offered by BioCentrum are performed with the highest quality standards and requirements set by the industry, as well as it shows that BioCentrum possesses adequate facilities and equipment, as well as employs a team of professionals who guarantee the highest standards of quality in all performed work.

"GLP Certification is an extremely important stage in the development of our company. This certification is an indication that all the services and research done by us in the field of cell and molecular biology are conducted in accordance with the highest international standards of Good Laboratory Practice. This certification is also a confirmation that our standards of work in the laboratory are identical with those of the finest laboratories in the world. Since the very beginning of BioCentrum we’ve been striving to deliver our customers with the highest quality of services, GLP certification is a confirmation that we’ve been able to achieve that, " said Dr Milosz Gruca, BioCentrum’s R&D Director and Member of the Board.

Other news from the department politics & laws

Most read news

More news from our other portals

Fighting cancer: latest developments and advances